Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ensysce Biosciences (ENSC) Other Non Operating Income (2021 - 2025)

Historic Other Non Operating Income for Ensysce Biosciences (ENSC) over the last 5 years, with Q3 2025 value amounting to $17338.0.

  • Ensysce Biosciences' Other Non Operating Income rose 1808.21% to $17338.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $83918.0, marking a year-over-year increase of 51188.77%. This contributed to the annual value of $17277.0 for FY2024, which is 1204.28% up from last year.
  • According to the latest figures from Q3 2025, Ensysce Biosciences' Other Non Operating Income is $17338.0, which was up 1808.21% from $21011.0 recorded in Q2 2025.
  • Over the past 5 years, Ensysce Biosciences' Other Non Operating Income peaked at $712899.0 during Q2 2021, and registered a low of -$39585.0 during Q1 2021.
  • In the last 5 years, Ensysce Biosciences' Other Non Operating Income had a median value of $9854.5 in 2022 and averaged $50456.8.
  • Over the last 5 years, Ensysce Biosciences' Other Non Operating Income had its largest YoY gain of 47289.63% in 2024, and its largest YoY loss of 73644.58% in 2024.
  • Ensysce Biosciences' Other Non Operating Income (Quarter) stood at $61758.0 in 2021, then increased by 8.05% to $66729.0 in 2022, then crashed by 111.93% to -$7962.0 in 2023, then soared by 472.9% to $29690.0 in 2024, then crashed by 41.6% to $17338.0 in 2025.
  • Its Other Non Operating Income stands at $17338.0 for Q3 2025, versus $21011.0 for Q2 2025 and $15879.0 for Q1 2025.